In the Lovenox patent case where MNTA sued Amphastar and TEVA in US District Court, TEVA was able to get a summary dismissal by simply showing that TEVA’s Lovenox was produced in Italy and therefore not subject to a US manufacturing patent.
Why to have a mfg. patent then? You can always dodge that simply by manufacturing out of US? I don't think it would be that simple...
And if that's true, MNTA seems to foolish as they have handed-over their mfg. secrets to other exUS manufacturers to copy.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.